Kircik, Leon

Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

Wollenberg, A., Blauvelt, A., Guttman‐Yassky, E., Worm, M., Lynde, C., Lacour, J. ‐., Spelman, L., Katoh, N., Saeki, H., Poulin, Y., et al. (2021) · British Journal of Dermatology

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 638

The primary role of sebum in the pathophysiology of acne vulgaris and its therapeutic relevance in acne management

Del Rosso, J. Q., & Kircik, L. (2024) · Journal of Dermatological Treatment

Acne and Rosacea Treatments and EffectsDermatology and Skin Diseases

Cited by 68

Efficacy and safety of a fixed-dose clindamycin phosphate 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel for moderate-to-severe acne: a randomized phase II study of the first triple-combination drug

Stein Gold, L., Baldwin, H., Kircik, L. H., Weiss, J. S., Pariser, D. M., Callender, V., Lain, E., Gold, M., Beer, K., Draelos, Z., et al. (2022) · American Journal of Clinical Dermatology

Acne and Rosacea Treatments and EffectsDermatology and Skin Diseases

Cited by 51

Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: a phase 3 study

Raoof, T. J., Hooper, D., Moore, A., Zaiac, M., Sullivan, T., Kircik, L., Lain, E., Jankicevic, J., & Stuart, I. (2020) · Journal of the American Academy of Dermatology

Acne and Rosacea Treatments and EffectsDermatology and Skin Diseases

Cited by 47

Isotretinoin Laboratory Monitoring in Acne Treatment: A Delphi Consensus Study

Xia, E., Han, J., Faletsky, A., Baldwin, H., Beleznay, K., Bettoli, V., Dréno, B., Goh, C. L., Stein Gold, L., Gollnick, H., et al. (2022) · JAMA Dermatology

Acne and Rosacea Treatments and EffectsDermatology and Skin Diseases

Cited by 40